Kenneth R. Chien

Kenneth Randall Chien
Kenneth Randall Chien
Nationality	American
Alma mater	Harvard College; Temple University;
Known for	Research in the field of cardiovascular biotechnology and regenerative cardiovascular medicine; Co-founding Moderna;
Parent	Luther Chien (father)
Awards	Pasarow Award (1996)
	Scientific career
Fields	Cardiovascular research; Regenerative cardiovascular medicine; Stem cell research; Biotechnology;
Institutions	Harvard University; Temple University; UC San Diego-Salk Institute; Massachusetts General Hospital; Karolinska Institute (Swedish: Karolinska Institutet);

Kenneth R. Chien (born 1951) is an American doctor and medical scientist who has been a research director at Karolinska Institute, in Stockholm, since 2013. Chien has several papers with over 1,000 citations and a h-index of 132. His area of expertise is cardiovascular science. His research into regenerative cardiovascular medicine, specifically while director of the Cardiovascular Program of the Harvard Stem Cell Institute, led to his co-founding, in 2010, of ModeRNA Therapeutics. In 2018, the company re-branded as Moderna, Inc. Chien is a recipient of the Walter Bradford Cannon Award of the American Physiology Society and the Pasarow Award. He is a member of the Norwegian Academy of Science and Letters, the Austrian Academy of Sciences, and has received an honorary doctorate from the University of Edinburgh.